aripiprazole · Xiamen Lp Pharm Co · NDA 216655
Opipza
Earliest generic entry, as listed · earliest of 3 marketed strengths
15 Dec 2041
Blocked by patent: US 11701352.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 11701352 | drug product · sets the listed date | 15 Dec 2041 |
| US 11331315 | drug product | 3 Nov 2040 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 3
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 216655 · 001 · RLD | film, oral | 2MG | 15 Dec 2041 |
| 216655 · 002 · RLD | film, oral | 5MG | 15 Dec 2041 |
| 216655 · 003 · RLD | film, oral | 10MG | 15 Dec 2041 |